Divya Abraham,MBBS, MPH(c)
@DivyaAbraham8
Followers
132
Following
174
Media
3
Statuses
54
🇮🇳🇺🇲🌎 Physician from India ## Clinical Researcher@ Harvard Med## Public/ Global Health Advocate@ Bridgeport Univ
Texas, USA
Joined July 2022
🚨Excited to be part of an RCT !!! Read our 📜 on Design of the EKSTROM Trial Colchicine is underutilized despite 3 positive outcome studies. We will be assessing its effect on Coronary Plaque and Pericoronary adipose tissue @BudoffMd @NCHRooneyHeart
https://t.co/6meefDMOIH
0
7
31
🔑 Colchicine 0.5 mg daily is FDA-approved for secondary prevention in patients w/ coronary artery disease. Read key points to remember from a state-of-the-art review on the long-term safety of low-dose colchicine for atherosclerosis: https://t.co/dklamPVGii
#cvPrev
acc.org
John D. Bisognano, MD, PhD, FACC
2
148
368
0
1
2
I'm not surprised that some individuals are making false accusations about The Match Guy Business. It seems that every successful business attracts its fair share of critics. Here are a few undeniable FACTS to set the record straight:
7
2
31
#FMRevolution I am a US Citizen and IMG, completed post grad Clinical Research from Harvard Medical School, with a purpose to provide compassionate primary care to all. Applicant for FM or IM residency focussed on primary care AAMC 13247624. Recent poster presentation at AMA.
3
2
24
Nomophobia = an unknown fear of being away from your cell or loss of connectivity. It's real and we all may have it!! Great collaboration and mentoring @_GRRSP
1
1
9
A true inspirer!! Congrats 🎉
So Honored to have been awarded the physician if the year award by the California chapter of the ACC. So many great clinicians and researchers. Truly humbled. @ACCinTouch
0
0
1
CAC helps personalize aspirin requirements!!
Day 1 #AHA23. Excited to present our work on #CAC in #CVPrevention
@NCHRooneyHeart @HarborUCLA @RCubedduMD @malbag1 @md_viviana @CarlOrrirnger @NCHFlorida @nch_im @hopkinsheart @WFCardiology @FloridaACC @ACCinTouch
0
0
0
# AI for CAC#
🔥💥Hot off the press ... Read our paper led by @JairoaldanaMD on Artificial Intelligence (AI) vs expert Level-3 human readers for the assessment and quantification of CAC #yesCCT @BudoffMd @ronaldkarlsberg @ManuboluSanjay @HarborUCLA
@NCHRooneyHeart
https://t.co/pfZfYCNvjn
0
0
1
1st annual #GRRSPCongress23, coming to you in 3 days! 😀 We at @_GRRSP are extremly grateful for the overwhelming response we have received from our worthy keynote speakers, panelists, judges, partners and the participants! Let's talk #MentoringInHealthcare on 30/4.
1
10
17
#Health care and Health equity, a must for all #
It’s the fourth day of Global Public Health Week, led by the World Federation of Public Health Associations, and today’s focus is “Making health a human right”.
0
0
0
Healthy diet a defence against Inflammation, Cancer, Heart diseases , DM,arthritis & Alzheimer's!!
Doctors are learning that one of the best ways to reduce #inflammation lies not in the medicine cabinet, but in the refrigerator. By following an anti-inflammatory diet you can fight off inflammation for good. #HarvardHealth
https://t.co/ba8nXOTfpQ
0
0
0
CVD and Cancer reduction via simple 7 ways
Preventing CV risk factors may not only reduce incident #CVD but also #cancer. Learn more in this intriguing study from the team at @parcc_inserm: https://t.co/2BdmKEEjTq
#JACCCardioOnc #CardioOnc #cvPrev
0
0
0
Awesome start to another glorious week of incredible learning @Dr_SRKashyap @DrAishKhalid @Hansmautong_08 @swissarmynurse
Day 1 of the Global Clinical Scholars Research Training Program workshop 3 at Harvard Medical School. Terrific IRB simulation - a real protocol at Boston Children’s. Susan Kornetsky, administrative head of the IRB at Children’s discusses challenges of consent in pediatric trials.
0
0
1
@harvardmed #GCSRT2023 workshop#3 @Dr_SRKashyap @DrAishKhalid @IvanHuespe3 @DivyaAbraham8 @Hansmautong_08 @jolivramento @DoctorAjaySingh
Day 1 of the Global Clinical Scholars Research Training Program workshop 3 at Harvard Medical School. Terrific IRB simulation - a real protocol at Boston Children’s. Susan Kornetsky, administrative head of the IRB at Children’s discusses challenges of consent in pediatric trials.
0
1
3
# Add on EPA to reduce CV risks#
Our analysis of the RESPECT Trial (EPA and outcomes, AHA 2022) is now published
0
0
0
# CCTA superior in LAA clot assessment#
#CCTA is an excellent modality for assessment of LAA clot Sensitivity(S)-100% Specificity(Sp) 70-96% With a 45 second delayed scan S-100% Sp -98-100% Multidisciplinary team approach @PU84 @GCudemusMD @md_viviana @DrPomeranz allowed for r/o of LAA clot DCCV and early discharge
0
0
0
# IPE required in high TG pts for a longer life#
22% event reduction in only 2640 patients outcome study. If reduce-it showed 26%, then chss as lK up 3-4% for mineral oil and you still have >20% reduction with epa. Better than pcsk9I. Finally it is time to show some RESPECT.
0
0
0